Bruce Japsen, Senior Contributor

Author's posts

Blue Cross Plans Will Back Nonprofit Drug Maker’s Cheaper Insulin

Blue Cross and Blue Shield health insurance companies say they will join nonprofit drug maker Civica Rx’s effort to make and sell cheaper versions of insulin at more than $30 per vial.

Biden’s Mental Health Strategy Fits Insurers’ ‘Whole Person’ Wheelhouse

President Joe Biden’s proposal to invest more in mental health should compliment an effort by health insurers to integrate behavioral care with medical treatment.

Cigna Latest Health Insurer To Increase Venture Spending On Startups And Digital Tech

Cigna will increase spending by $450 million on startup businesses and digital health via its Cigna Ventures fund.

Poll: Half Of U.S. Worries Deaths Will Rise If Pandemic Restrictions End

Americans are worried about the end of mask mandates and pandemic restrictions with about half worried about increased deaths if their communities “lift pandemic restrictions.”

Centene CEO Neidorff To Take Medical Leave

Centene chairman Michael Neidorff will take a “medical leave of absence” to address a “treatable medical condition,” the company said.

Walmart: 4 In 5 Covid Vaccines Went To ‘Medically Underserved’

Walmart administered 80% of its vaccines against Covid-19 in “medically underserved” areas of the U.S.

Global Health Pioneer Paul Farmer Dies

Global health pioneer and founder of Partners in Health Dr. Paul Farmer “unexpectedly passed away” Monday.

Oscar Health Loss Hits $197 Million Despite Record Obamacare Growth

Oscar Health reported a quarterly loss of nearly $198 million as the company invests more to grow its health insurance businesses, including Obamacare.

PPE Maker Medline’s Sales Eclipse $20 Billion During Pandemic’s Surge

Medical product maker Medline’s revenue eclipsed $20 billion last year, adding more than 230 new healthcare provider and health system accounts worth nearly $2 billion in 2020 sales.

Covid Vaccines And Testing Boost CVS Health Profits

CVS reported more than $1 billion in quarterly profits thanks to a rush of customers being vaccinated against Covid-19 or tested for the virus as the Omicron variant surged.